Clinical Trial Update: Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease. [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of droxidopa (NORTHERA) for dysautonomia in pediatric survivors of Menkes disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menkes Disease

Drugs mentioned

• Northera (droxidopa)

Snippet

Sponsor: Stephen G. Kaler | Conditions: Menkes Disease | Phase 1, Phase 2 | Status: RECRUITING